Global Antidepressants Market 2021 Industry Outlook, Comprehensive Insights, Growth and Forecast 2027

[Ankit Dwivedi]

The global antidepressants market size is projected to reach USD 18.29 billion by 2027, exhibiting a CAGR of 2.9% during the forecast period. The skyrocketing demand for depression management drugs amid the COVID-19 pandemic will rapidly broaden the horizons of this market, observes Fortune Business Insights™

Click here to get the short-term and long-term impacts of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/antidepressants-market-105017

List of Key Companies Covered in this Market Report:

• Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel)

• AstraZeneca (Cambridge, U.K)

• Pfizer Inc. (New York, U.S)

• Eli Lilly and Company (Indiana, U.S)

• H. Lundbeck A/S (Denmark, Europe)

• Bristol-Myers Squibb (New York, U.S)

• Merck & Co. Inc. (New Jersey, U.S)

• Janssen Pharmaceuticals (Beerse, Belgium)

• GlaxoSmithKline plc (Brentford, U.K)

Some major points from Table of Content:

• Introduction

  • Market Scope

  • Market Segmentation

  • Market Methodology

  • Definitions and Assumptions

• Executive Summary

• Market Dynamics

  • Market Drivers

  • Market Restraints

  • Market Opportunities

• Key Insights

  • Prevalence of Anxiety & Depression –Key Regions/Country

  • New Product Launch

  • Pipeline Analysis

  • Impact of COVID-19 on the Market

  • Key Industry Developments - Mergers, Acquisitions, and Partnerships

• Global Antidepressants Market Analysis, Insights and Forecast, 2016-2027

  • Key Findings / Summary

  • Market Analysis, Insights and Forecast – By Drug Class

    •  Selective Serotonin Reuptake Inhibitors (SSRIs)

    •  Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

    •  Atypical Antidepressants

    •  Tricyclic Antidepressants (TCAs)

    •  Monoamine Oxidase Inhibitors (MAOIs)

    •  Others

  • Market Analysis, Insights and Forecast – By Disorder

    •  Major Depressive Disorder

    •  Obsessive Compulsive Disorder

    •  Generalized Anxiety Disorder

    •   Panic Disorder

    •   Others

  • Market Analysis, Insights and Forecast – By Distribution Channel

    •  Hospital Pharmacy

    •  Retail Pharmacy

    •  Online Pharmacy

  • Market Analysis, Insights and Forecast – By Geography

    •  North America

    •  Europe

    •  Asia Pacific

    •  Latin America

    •  Middle East & Africa